Market Place
Sourcing Support
Novo Nordisk`s Ozempic cuts dementia risk vs. Merck`s Januvia
12 Jul 2024 //
FIERCE PHARMA
Activist demands regulatory probe overcharging of diabetic drug Janumet by MSD
02 Apr 2024 //
PHARMABIZ
Project Nitroso-Sitagliptin Impurity
07 Mar 2024 //
PRESS RELEASE
Ami successful filing of the USDMF for Sitagliptin Phosphate Monohydrate
23 Jan 2024 //
PRESS RELEASE
NeuroBo Pharmaceuticals Reports Positive Pre-Clinical Safety Data of DA-1241
18 Jan 2024 //
PR NEWSWIRE
Zydus receives USFDA approval for ZITUVIO™ to treat type 2 diabetes mellitus
20 Oct 2023 //
PR NEWSWIRE
Merck, Viatris agree to settle patent feud surrounding diabetes drugs
21 Mar 2023 //
ENDPTS
Pharma companies are launching generics of Sitagliptin post-patent expiry
26 Dec 2022 //
FINANCIALEXPRESS
Emmes acquires Clinical Edge; Expands global reach
30 Sep 2022 //
PHARMABIZ
US Court of Appeals for Circuit Rules in Favor of Merck in Patent Lawsuit
29 Sep 2022 //
BUSINESSWIRE
Govt launches diabetes drug Sitagliptin, its combinations at Rs 60/pack of 10
18 Sep 2022 //
THE PRINT
U.S. District Court Rules In Favor of Merck in Sitagliptin Patent Lawsuit
01 Sep 2022 //
PRESS RELEASE
FDA relaxes impurity limit on Merck`s Januvia. Are recalls next?
10 Aug 2022 //
FIERCE PHARMA
To avoid shortage of Merck`s diabetes drug, FDA allows higher impurity levels
10 Aug 2022 //
ENDPTS
Cadila launches generic versions of type 2 diabetes drug Sitagliptin in India
01 Aug 2022 //
ET HEALTH
Glenmark launches Sitagliptin for adults with type 2 diabetes
07 Jul 2022 //
ET HEALTH
Enforcement Report - Week of April 13, 2022
13 Apr 2022 //
FDA
Mylan`s Generics Sitagliptin & Metformin HCl Receives Approval in Europe
08 Mar 2022 //
EMA
Intas Pharms` Generic Sitagliptin Receives Approval in the U.S.
02 Mar 2022 //
FDA
Curative Potential for Diabetes, Alzheimer and Parkinson Seen in Research Data
26 Oct 2021 //
BUSINESSWIRE
Codexis & Merck Amend and Extend Supply Agreement for Enzyme Used in Sitagliptin
09 Sep 2021 //
GLOBENEWSWIRE
Unichem Labs gets tentative US FDA approval for Sitagliptin Tablets USP
09 Jul 2021 //
EXPRESS PHARMA
Ajanta Pharma`s Generic Sitagliptin Phosphate Receives Approval In US
09 Jan 2021 //
FDA
New studies show diabetes drug not proven to improve blood sugar control
07 Dec 2020 //
FDA
Diabetes drug could increase stem cells in the womb
08 Jan 2020 //
PHARMA FILE
Diabetes drug could increase stem cells in the womb
08 Jan 2020 //
PHARMA FILE
Diabetes drug could increase stem cells in the womb
07 Jan 2020 //
PHARMA FILE
Novo Nordisk targets bigger slice of diabetes market with new tablet
24 Sep 2019 //
REUTERS
Novo Nordisk isn`t disclosing Rybelsus price just yet
20 Sep 2019 //
ENDPTS
Oral semaglutide trumps Jardiance, Januvia, Victoza in type II diabetes
19 Sep 2019 //
PHARMATIMES
Novo Nordisk reports positive data for oral semaglutide
18 Sep 2019 //
CLINEICALTRIALSARENA
What`s at stake for pharma in Pelosi`s pricing plan? Megabillions
12 Sep 2019 //
FIERCE PHARMA
Merck scores a new Zerbaxa indication
05 Jun 2019 //
FIERCE PHARMA
Novo Nordisk files for EU approval of Ozempic in type II diabetes
26 Apr 2019 //
PHARMA TIMES
Novo’s oral semaglutide could disrupt diabetes coverage: analyst
05 Mar 2019 //
FIERCE PHARMA
Janumet (metformin hydrochloride; sitagliptin phosphate): Merck vs. Sandoz
15 Feb 2019 //
PATENT LITIGATION
Janumet (metformin hydrochloride; sitagliptin phosphate) : Merck vs. Mylan
14 Feb 2019 //
PATENT LITIGATION
Janumet (metformin HCl; sitagliptin phosphate) : Merck v. Macleods Pharma
13 Feb 2019 //
PATENT LITIGATION
Janumet (metformin hydrochloride; sitagliptin phosphate) : Merck v. Apotex
13 Feb 2019 //
PATENT LITIGATION
Janumet XR (metformin HCl; sitagliptin phosphate) : Merck v. Anchen Pharm
13 Feb 2019 //
PATENT LITIGATION
Janumet XR (metformin HCl; sitagliptin phosphate) : Merck vs. Alvogen PB
13 Feb 2019 //
PATENT LITIGATION
FDA raids traders ‘diverting’ drugs meant for defence
10 Feb 2019 //
ECONOMIC TIMES
Merck posts global sales of $11B in third quarter
25 Oct 2018 //
YAHOO FINANCE
Zydus Pharms USA`s Generic Sitagliptin Receives Tentative Approval in US
12 Sep 2018 //
FDA
Zydus gets US FDA tentative approval for sitagliptin tablets
11 Sep 2018 //
PHARMABIZ
Merck debuts new-and-improved diabetes coaching platform
30 Aug 2018 //
FIERCE PHARMA
Novo’s oral semaglutide hits targets in diabetics with renal impairment
21 Aug 2018 //
PHARMA TIMES
Novo’s oral semaglutide on target in phase 3 trial
20 Aug 2018 //
PHARMAPHORUM
Novo data buttress its oral semaglutide case in kidney-impaired patients
20 Aug 2018 //
FIERCE PHARMA
Novo trumpets more Januvia-topping data for oral semaglutide
30 Jun 2018 //
FIERCE PHARMA
Novo’s oral semaglutide bests MSD’s Januvia on HbA1c reduction
29 Jun 2018 //
PHARMA TIMES
Novo`s pioneering diabetes pill beats Victoza, Januvia in tests
21 Jun 2018 //
REUTERS
“Patient-Centricity”or “Pay-Per-Results” Is a Hot Topic
06 Jun 2018 //
BIOSPACE
Sun Pharma receives tentative approval for Metformin HCL, Sitagliptin Phosphate
12 Apr 2018 //
INDIAINFOLINE
Merck`s Steglujan (ertugliflozin / sitagliptin) Receives Approval In Europe
05 Apr 2018 //
EMA
Tracking a successful DLBCL assault in PhII, MorphoSys out to OK for MOR208
14 Mar 2018 //
PLATFORM
ACC-AstraZeneca unveil more SGLT2 heart benefits with latest batch of RWD
12 Mar 2018 //
FIERCE PHARMA
